DOV Pharmaceuticals has announced that dosing has been suspended in its ongoing trial of ocinaplon due to liver enzyme elevations

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1069, 2005-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alexza Pharmaceuticals has announced that it has completed enrolment in its second phase III trial with loxapine

By  

Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

A new funding initiative has been announced in South Korea

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 345, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

A-Viral has advised that a trial of AV 1101 has been temporarily suspended as it `seems likely' that AV 1101 200 mg/day, given in combination

By  

Reactions Weekly, Vol. 1, Iss. 1056, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Salix Pharmaceuticals has announced that rifaximin has effectively prevented the development of hepatic encephalopathy

By  

Inpharma, Vol. 1, Iss. 1660, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

A phase III trial of Reopro [abciximab] for the treatment of patients with acute ischaemic stroke (AbESTT-II) has been temporarily suspended

By  

Reactions Weekly, Vol. 1, Iss. 1073, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite